## **Core Concept**
Hemoglobin E (HbE) is a variant of hemoglobin that results from a mutation in the HBB gene, which codes for the beta-globin subunit of hemoglobin. This mutation leads to the substitution of lysine for glutamic acid at position 26 of the beta-globin chain. HbE is one of the most common hemoglobinopathies in the world and has significant public health implications in certain regions.

## **Why the Correct Answer is Right**
The correct answer, , is associated with Southeast Asia, particularly in countries such as Thailand, Cambodia, and Laos. HbE is prevalent in these areas due to the genetic adaptation of the population to malaria. The mutation provides some protection against malaria, which has been a significant selective pressure in these regions. Therefore, the high prevalence of HbE in Southeast Asia is a result of this genetic protective mechanism.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This region is not particularly known for a high prevalence of HbE. While hemoglobinopathies can be found worldwide, the specific distribution of HbE is more limited.
* **Option B:** - Although Africa has a high diversity of hemoglobinopathies due to its large population and genetic diversity, HbE is not specifically common in this region compared to Southeast Asia.
* **Option C:** - This option might be considered due to the presence of various hemoglobinopathies, but it is not specifically known for HbE.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that HbE disease often presents as a mild form of beta-thalassemia. Individuals with HbE trait (heterozygous for HbE) are generally asymptomatic or have mild microcytic anemia, while those with HbE disease (homozygous for HbE) can have more pronounced symptoms, including moderate to severe anemia and splenomegaly.

## **Correct Answer:** . Southeast Asia